Ikawa M - Search Results

1

Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.

Okada Y, Ueshin Y, Hasuwa H, Takumi K, Okabe M, Ikawa M. Okada Y, et al. Among authors: ikawa m. Genesis. 2009 Apr;47(4):217-23. doi: 10.1002/dvg.20469. Genesis. 2009. PMID: 19208434

2

Homology of an acrosome-reacted sperm-specific antigen to CD46.

Okabe M, Ying X, Nagira M, Ikawa M, Kohama Y, Mimura T, Tanaka K. Okabe M, et al. Among authors: ikawa m. J Pharmacobiodyn. 1992 Aug;15(8):455-9. doi: 10.1248/bpb1978.15.455. J Pharmacobiodyn. 1992. PMID: 1479546

3

A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP).

Ikawa M, Kominami K, Yoshimura Y, Tanaka K, Nishimune Y, Okabe M. Ikawa M, et al. FEBS Lett. 1995 Nov 13;375(1-2):125-8. doi: 10.1016/0014-5793(95)01162-8. FEBS Lett. 1995. PMID: 7498460 Free article.

4

Improvement of fusing ability of human sperm to zona-free hamster eggs by conditioned media.

Ikawa M, Ying X, Tanaka K, Ohashi K, Saji F, Okabe M. Ikawa M, et al. Biol Pharm Bull. 1995 Jan;18(1):5-8. doi: 10.1248/bpb.18.5. Biol Pharm Bull. 1995. PMID: 7735250 Free article.

5

[What does sperm recognize on fusing cells?].

Ikawa M, Okabe M. Ikawa M, et al. Seikagaku. 1993 Nov;65(11):1429-33. Seikagaku. 1993. PMID: 8294782 Review. Japanese. No abstract available.

6

Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.

Kawagoe K, Kitamura D, Okabe M, Taniuchi I, Ikawa M, Watanabe T, Kinoshita T, Takeda J. Kawagoe K, et al. Among authors: ikawa m. Blood. 1996 May 1;87(9):3600-6. Blood. 1996. PMID: 8611683 Free article.

7

In vitro and in vivo studies to prevent hyperacute rejection.

Miyagawa S, Mikata M, Matsuda H, Ikawa M, Okabe M, Nagasawa S, Matsumoto M, Seya T, Shirakura R. Miyagawa S, et al. Among authors: ikawa m. Transplant Proc. 1996 Apr;28(2):1031-3. Transplant Proc. 1996. PMID: 8623217 No abstract available.

8

Difference of expression levels between gene technological product delta CYT-MCP(CD46) and intact MCP(CD46) in transgenic mice.

Miyagawa S, Ikawa M, Kominami K, Yoshimura Y, Tanaka H, Mikata S, Shirakura R, Matsuda H, Yanagi Y, Seya T, Okabe M. Miyagawa S, et al. Among authors: ikawa m. Transplant Proc. 1996 Apr;28(2):585-6. Transplant Proc. 1996. PMID: 8623285 No abstract available.

9

Transcriptional activation of a hybrid promoter composed of cytomegalovirus enhancer and beta-actin/beta-globin gene in glomerular epithelial cells in vivo.

Akagi Y, Isaka Y, Akagi A, Ikawa M, Takenaka M, Moriyama T, Yamauchi A, Horio M, Ueda N, Okabe M, Imai E. Akagi Y, et al. Among authors: ikawa m. Kidney Int. 1997 Apr;51(4):1265-9. doi: 10.1038/ki.1997.172. Kidney Int. 1997. PMID: 9083295 Free article.

10

The regulation of membrane cofactor protein (CD46) expression in transgenic mice: the importance of the first 125 BP of the 3' untranslated region.

Miyagawa S, Ikawa M, Kominami K, Tanaka H, Mikata S, Matsuda H, Seya T, Shirakura R, Okabe M. Miyagawa S, et al. Among authors: ikawa m. Transplant Proc. 1997 Feb-Mar;29(1-2):941-2. doi: 10.1016/s0041-1345(96)00266-7. Transplant Proc. 1997. PMID: 9123597 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

596 results

Search Page

Filters